Literature DB >> 20214886

Different effects of 25-kDa amelogenin on the proliferation, attachment and migration of various periodontal cells.

Xiting Li1, Rong Shu, Dali Liu, Shaoyun Jiang.   

Abstract

Previous studies have assumed that amelogenin is responsible for the therapeutic effect of the enamel matrix derivative (EMD) in periodontal tissue healing and regeneration. However, it is difficult to confirm this hypothesis because both the EMD and the amelogenins are complex mixtures of multiple proteins. Further adding to the difficulties is the fact that periodontal tissue regeneration involves various types of cells and a sequence of associated cellular events including the attachment, migration and proliferation of various cells. In this study, we investigated the potential effect of a 25-kDa recombinant porcine amelogenin (rPAm) on primarily cultured periodontal ligament fibroblasts (PDLF), gingival fibroblasts (GF) and gingival epithelial cells (GEC). The cells were treated with 25-kDa recombinant porcine amelogenin at a concentration of 10 microg/mL. We found that rPAm significantly promoted the proliferation and migration of PDLF, but not their adhesion. Similarly, the proliferation and adhesion of GF were significantly enhanced by treatment with rPAm, while migration was greatly inhibited. Interestingly, this recombinant protein inhibited the growth rate, cell adhesion and migration of GEC. These data suggest that rPAm may play an essential role in periodontal regeneration through the activation of periodontal fibroblasts and inhibition of the cellular behaviors of gingival epithelial cells. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214886     DOI: 10.1016/j.bbrc.2010.03.023

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  The role of cell surface markers and enamel matrix derivatives on human periodontal ligament mesenchymal progenitor responses in vitro.

Authors:  Philippe Kémoun; Stan Gronthos; Malcolm L Snead; Jacqueline Rue; Bruno Courtois; Frédéric Vaysse; Jean-Pierre Salles; Gérard Brunel
Journal:  Biomaterials       Date:  2011-07-23       Impact factor: 12.479

2.  Analogous effects of recombinant human full-length amelogenin expressed by Pichia pastoris yeast and enamel matrix derivative in vitro.

Authors:  L Cheng; Z K Lin; R Shu; D L Liu; X L Zhang; B Liu; J Wang; L Tian
Journal:  Cell Prolif       Date:  2012-07-26       Impact factor: 6.831

3.  Enamel matrix derivative improves gingival fibroblast cell behavior cultured on titanium surfaces.

Authors:  Yulan Wang; Yufeng Zhang; Dai Jing; Yang Shuang; Richard J Miron
Journal:  Clin Oral Investig       Date:  2015-08-14       Impact factor: 3.573

4.  Skeletal ligament healing using the recombinant human amelogenin protein.

Authors:  Salem Hanhan; Ayala Ejzenberg; Koby Goren; Faris Saba; Yarden Suki; Shay Sharon; Dekel Shilo; Jacob Waxman; Elad Spitzer; Ron Shahar; Ayelet Atkins; Meir Liebergall; Anat Blumenfeld; Dan Deutsch; Amir Haze
Journal:  J Cell Mol Med       Date:  2016-02-24       Impact factor: 5.310

5.  Effects of enamel matrix proteins on adherence, proliferation and migration of epithelial cells: A real-time in vitro study.

Authors:  Marzena Wyganowska-Swiatkowska; Paulina Urbaniak; Daniel Lipinski; Marlena Szalata; Karolina Borysiak; Jerzy Jakun; Malgorzata Kotwicka
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

6.  Human gingival fibroblast response to enamel matrix derivative, porcine recombinant 21.3-kDa amelogenin and 5.3-kDa tyrosine-rich amelogenin peptide.

Authors:  Marzena Wyganowska-Swiatkowska; Paulina Urbaniak; Daniel Lipinski; Marlena Szalata; Malgorzata Kotwicka
Journal:  Hum Cell       Date:  2017-05-03       Impact factor: 4.174

7.  MicroRNA-146 inhibits pro-inflammatory cytokine secretion through IL-1 receptor-associated kinase 1 in human gingival fibroblasts.

Authors:  Yu-Feng Xie; Rong Shu; Shao-Yun Jiang; Da-Li Liu; Jing Ni; Xiu-Li Zhang
Journal:  J Inflamm (Lond)       Date:  2013-05-16       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.